StructureMoa is a chemical-structure exploration tool. Structural similarity, clustering, and SAR relationships are intended for research exploration and do not establish shared potency, selectivity, safety, efficacy, or clinical performance.

Core structure exploration tiers

Rule-based Catalog Exploration Score from SMILES similarity, approved/clinical tags, family network size, and SAR metadata. It does not predict efficacy, safety, or development success.

StructureMoa is a chemical-structure exploration tool. Structural similarity, clustering, and SAR relationships are intended for research exploration and do not establish shared potency, selectivity, safety, efficacy, or clinical performance.

Core 후보 59파생 후보 24041 패밀리

HighHigh exploration priority2

Highest Exploration Score percentile in this pool (X-S bin)

High exploration priority2DStructureClassExploration ScoreFactors
High
Dolastatin 10 / auristatin core
MMAE (auristatin) payload family · Scaffold
ADC payload100패밀리 core · Pharmacophore · SMILES 확보 · SAR/core
High
Duocarmycin CPI core
Duocarmycin CPI ADC payload series · Scaffold
ADC payload99패밀리 core · Pharmacophore · SMILES 확보 · SAR/core

Duocarmycin CPI ADC payload series · Scaffold · ADC payload

패밀리 core · Pharmacophore · SMILES 확보 · SAR/core

MedMedium exploration priority3

Upper-mid Exploration Score percentile (X-A bin)

High exploration priority2DStructureClassExploration ScoreFactors
Med
Enediyne warhead core
Calicheamicin enediyne payload family · Scaffold
ADC payload96패밀리 core · Pharmacophore · SMILES 확보 · SAR/core
Med
PBD monomer (anthramycin lineage)
PBD dimer ADC payload family · Scaffold
ADC payload96패밀리 core · Pharmacophore · SMILES 확보 · SAR/core
Med
MMAE (monomethyl auristatin E)
MMAE (auristatin) payload family · Payload
ADC payload91Payload core · SMILES 확보 · 승인·상용 신호 · 패밀리 12종

Calicheamicin enediyne payload family · Scaffold · ADC payload

패밀리 core · Pharmacophore · SMILES 확보 · SAR/core

MMAE (auristatin) payload family · Payload · ADC payload

Payload core · SMILES 확보 · 승인·상용 신호 · 패밀리 12종

MedMedium exploration priority5

Mid-pool Exploration Score (X-B bin)

High exploration priority2DStructureClassExploration ScoreFactors
Med
Duocarmycin SA
Duocarmycin CPI ADC payload series · Payload
ADC payload64Payload core · SMILES 확보 · 파생 2건 · 고관심 계열
Med
MMAF (monomethyl auristatin F)
MMAE (auristatin) payload family · Payload
ADC payload64Payload core · SMILES 확보 · 패밀리 12종 · 고관심 계열
Med
N-acetyl-γ-calicheamicin
Calicheamicin enediyne payload family · Payload
ADC payload64Payload core · SMILES 확보 · 파생 2건 · 고관심 계열
Med
SG3199 (PBD dimer warhead)
PBD dimer ADC payload family · Payload
ADC payload64Payload core · SMILES 확보 · 파생 2건 · 고관심 계열
Med
Auristatin E (parent)
MMAE (auristatin) payload family · Scaffold
ADC payload63Pharmacophore · SMILES 확보 · 패밀리 12종 · 고관심 계열

Duocarmycin CPI ADC payload series · Payload · ADC payload

Payload core · SMILES 확보 · 파생 2건 · 고관심 계열

MMAE (auristatin) payload family · Payload · ADC payload

Payload core · SMILES 확보 · 패밀리 12종 · 고관심 계열

Calicheamicin enediyne payload family · Payload · ADC payload

Payload core · SMILES 확보 · 파생 2건 · 고관심 계열

PBD dimer ADC payload family · Payload · ADC payload

Payload core · SMILES 확보 · 파생 2건 · 고관심 계열

MMAE (auristatin) payload family · Scaffold · ADC payload

Pharmacophore · SMILES 확보 · 패밀리 12종 · 고관심 계열

LowLow exploration priority7

Lower Exploration Score — still listed for inspection (X-C bin)

High exploration priority2DStructureClassExploration ScoreFactors
Low
Calicheamicin γ¹
Calicheamicin enediyne payload family · Payload
ADC payload61Payload core · SMILES 확보 · 고관심 계열
Low
Tesirine (SG3249)
PBD dimer ADC payload family · Payload
ADC payload61Payload core · SMILES 확보 · 고관심 계열
Low
Seco-duocarmycin
Duocarmycin CPI ADC payload series · Payload
ADC payload56Payload core · SMILES 확보 · 고관심 계열
Low
Val-Cit
MMAE (auristatin) payload family · Linker
ADC payload55Linker hub · SMILES 확보 · 패밀리 12종 · 고관심 계열
Low
Acyl hydrazone linker
Calicheamicin enediyne payload family · Linker
ADC payload52Linker hub · SMILES 확보 · 고관심 계열
Low
Val-Ala PBD linker
PBD dimer ADC payload family · Linker
ADC payload52Linker hub · SMILES 확보 · 고관심 계열
Low
Duocarmycin Val-Cit linker node
Duocarmycin CPI ADC payload series · Linker
ADC payload50Linker hub · SMILES 확보 · 고관심 계열

Calicheamicin enediyne payload family · Payload · ADC payload

Payload core · SMILES 확보 · 고관심 계열

PBD dimer ADC payload family · Payload · ADC payload

Payload core · SMILES 확보 · 고관심 계열

Duocarmycin CPI ADC payload series · Payload · ADC payload

Payload core · SMILES 확보 · 고관심 계열

MMAE (auristatin) payload family · Linker · ADC payload

Linker hub · SMILES 확보 · 패밀리 12종 · 고관심 계열

Calicheamicin enediyne payload family · Linker · ADC payload

Linker hub · SMILES 확보 · 고관심 계열

PBD dimer ADC payload family · Linker · ADC payload

Linker hub · SMILES 확보 · 고관심 계열

Exploration score method

StructureMoa ranks are a rule-based Exploration Score. An LLM does not predict activity or efficacy. Role, SMILES, and relation signals inside each family are summed and cut into High / Medium / Low exploration priority.

Core tab

  • scaffold / payload / linker role weights
  • family center-compound bonus
  • SMILES source (db · known · pubchem · inherited)
  • relation-edge count and derived-child count

Derivative tab

  • drug / derivative / adc candidates
  • similarity to family center via Morgan fingerprint, radius 2, 2048 bits, Tanimoto
  • approved / clinical catalog-tag bonuses
  • ADC / payload tags

Explore tab

  • sparse SAR, cross-scaffold pairs, expansion leaves
  • weakly linked nodes and approved-tag neighborhood gaps
  • relation graph + stored Morgan fingerprints
  • category filters

Exploration-priority bins

  • High (X-S): top ~12%
  • Medium (X-A/X-B): ~12–62%
  • Low (X-C): remainder (pools under 5 compounds stay Medium)

Internal exploration metric based on catalog and structural signals. Not a prediction of efficacy, safety, potency, or development success.

Full methodology

평가 시각: 2026. 9. 11. 오전 4:01:55 · 캐시 5분 · 전체 패밀리